2020
DOI: 10.3390/biology9110374
|View full text |Cite
|
Sign up to set email alerts
|

Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients

Abstract: The pandemic virus SARS-CoV-2 has been reported to be able to enter the body via the eye conjunctiva, but the presence of antiviral response in the eye remains poorly known. Our study was thus aimed to analyze the presence of secretory mucosal anti-SARS-CoV-2 type A immunoglobulins (IgA) in the conjunctival fluid of COVID-19 patients. The tears of 28 COVID-19 patients and 20 uninfected controls were collected by the Schirmer test and analyzed by a specific ELISA assay detecting anti-spike (S1) virus protein Ig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
32
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(34 citation statements)
references
References 38 publications
2
32
0
Order By: Relevance
“…A still unanswered point in COVID-19 progression regards the development and role of the local immune response against SARS-CoV-2. Mucosal sIgA has long been known to be crucial in controlling viruses that enter the body via mucosal surfaces ( Yan et al, 2002 ); sIgA were indeed found in the ocular fluid of at least 40% of COVID-19 patients ( Caselli et al, 2020b ), and microbiome composition is reportedly known to interact with and influence IgA response, in different anatomical niches including the nares ( Salk et al, 2016 ; Grosserichter-Wagener et al, 2019 ; Pabst and Slack, 2020 ). Here, we demonstrate anti-SARS-CoV-2 sIgA in the oral cavity and that they are significantly more abundant in asymptomatic/paucisymptomatic COVID-19 patients ( p = 0.02), suggesting that sIgA may be important in controlling virus penetration in the body.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A still unanswered point in COVID-19 progression regards the development and role of the local immune response against SARS-CoV-2. Mucosal sIgA has long been known to be crucial in controlling viruses that enter the body via mucosal surfaces ( Yan et al, 2002 ); sIgA were indeed found in the ocular fluid of at least 40% of COVID-19 patients ( Caselli et al, 2020b ), and microbiome composition is reportedly known to interact with and influence IgA response, in different anatomical niches including the nares ( Salk et al, 2016 ; Grosserichter-Wagener et al, 2019 ; Pabst and Slack, 2020 ). Here, we demonstrate anti-SARS-CoV-2 sIgA in the oral cavity and that they are significantly more abundant in asymptomatic/paucisymptomatic COVID-19 patients ( p = 0.02), suggesting that sIgA may be important in controlling virus penetration in the body.…”
Section: Discussionmentioning
confidence: 99%
“…The presence of anti-SARS-CoV-2 secretory IgA (sIgA) in the oral samples was evaluated by a CE-IVD ELISA assay designed to detect IgA directed against the virus S1 protein (Euroimmun, Lubeck, Germany). The test was previously reported to have high specificity/sensitivity for IgA detection in serum/plasma samples (>95%) and ocular fluids ( Caselli et al, 2020b ). For oral rinse analysis, the samples were diluted 1:5 in saline, allowing optimal detection of IgA and differentiation between positive samples and controls, as detected in preliminary assays.…”
Section: Methodsmentioning
confidence: 99%
“…The window for virus detection in conjunctival swabs may be no wider than three days [ 47 ], although cases with viral persistence of more than two weeks in the conjunctiva have been reported [ 14 , 48 ]. Moreover, tears contain lactoferrin, a natural immunity molecule endowed with antiviral properties [ 49 , 50 ], and secretory IgA [ 51 ], which can also be specifically elicited by SARS-CoV-2 infection [ 52 ]. Therefore, the low frequency of overt SARS-CoV-2 infections reported in our study can be considered in line with the expectations.…”
Section: Discussionmentioning
confidence: 99%
“…The presence of IgA in the tears suggests the potential shedding of the virus through tears and infectivity through tears and conjunctival secretions. 20 …”
Section: Discussionmentioning
confidence: 99%
“…This differs from other studies that show no correlation. 20 This can be explained by the idea that ocular symptoms could occur as an immune response and become more evident when there is a greater immune response in the form of virus/IgA interaction. Confirmation of this explanation requires further investigation.…”
Section: Discussionmentioning
confidence: 99%